
    
      This will be a single-center randomized double blind placebo control clinical trial. In the
      cohort of patients undergoing primary elective total hip and the cohort of patients
      undergoing primary elective knee arthroplasty, participants are recruited from those who are
      willing to consent and participate in the study, and will be randomly 1:1 divided into
      intervention group and placebo group.
    
  